Agilent Technologies Inc at Goldman Sachs Healthcare Conference Transcript
This morning. I'm Matt Sykes, the life sciences tools and diagnostics analyst at Goldman Sachs. It's a pleasure to welcome Bob McMahon, CFO of Agilent to the stage today. Bob, thank you very much for coming.
Thank you. It's a pleasure to be here.
Questions & Answers
Great. Maybe I'll let you kind of set the stage first and talk about your most recent results and sort of trends you're seeing in your business as we enter the second half of this year.
Yes. We -- through the first half of the year, we're actually very pleased with the performance of the company. We actually had very solid results in the second quarter, 9.5% core growth and actually 12%
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
